Objectives. This study was constructed so as to screen malignant trans
formation after uroenteric reconstructions using bowel segments expose
d to urine without fecal stream for more than 10 years. Methods. Follo
w-up data were available for 186 patients who underwent various uroent
eric reconstructions using bowel segments exposed to urine without fec
al stream for more than 10 years. There were 68 eligible patients with
isolated rectosigmoid bladder, 23 with bladder augmentations (15 ileo
cystoplasty and 8 colocystoplasty), 57 with ileal ureter, and 38 with
ileal loop conduit. Besides routine laboratory and radiologic investig
ations, urine for cytology was obtained from all patients. Moreover, e
ndoscopy and random biopsy of the part of bowel exposed to urine were
carried out in all patients. Results. Uroenteric malignancy was diagno
sed in 4 patients (2%): 2 adenocarcinoma in an isolated rectosigmoid b
ladder, 1 transitional cell carcinoma following augmentation colocysto
plasty, and 1 squamous cell carcinoma after ileal ureter. None of the
patients developed tumors in ileal loop conduits. Conclusions. Maligna
nt changes do not only occur after ureterosigmoidostomy but are also o
bserved after different uroenteric reconstructions not exposed to feca
l stream. Hematuria, ureteral obstruction, and abnormal urine cytology
are warning signs of malignancy. Routine cytology is recommended at l
east yearly beginning 10 years after surgery.